{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T18:22:59Z","timestamp":1793384579717,"version":"4.5.0"},"reference-count":134,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2023,2,21]],"date-time":"2023-02-21T00:00:00Z","timestamp":1676937600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Italian Ministry of University and Research"},{"name":"Scuola Sant\u2019Anna"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomedicines"],"abstract":"<jats:p>MicroRNAs (miRNAs) are small non-coding RNAs with the crucial regulatory functions of gene expression at post-transcriptional level, detectable in cell and tissue extracts, and body fluids. For their stability in body fluids and accessibility to sampling, circulating miRNAs and changes of their concentration may represent suitable disease biomarkers, with diagnostic and prognostic relevance. A solid literature now describes the profiling of circulating miRNA signatures for several tumor types. Among body fluids, saliva accurately reflects systemic pathophysiological conditions, representing a promising diagnostic resource for the future of low-cost screening procedures for systemic diseases, including cancer. Here, we provide a review of literature about miRNAs as potential disease biomarkers with regard to ovarian cancer (OC), with an excursus about liquid biopsies, and saliva in particular. We also report on salivary miRNAs as biomarkers in oncological conditions other than OC, as well as on OC biomarkers other than miRNAs. While the clinical need for an effective tool for OC screening remains unmet, it would be advisable to combine within a single diagnostic platform, the tools for detecting patterns of both protein and miRNA biomarkers to provide the screening robustness that single molecular species separately were not able to provide so far.<\/jats:p>","DOI":"10.3390\/biomedicines11030652","type":"journal-article","created":{"date-parts":[[2023,2,22]],"date-time":"2023-02-22T03:59:16Z","timestamp":1677038356000},"page":"652","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Circulating Biomarkers for Cancer Detection: Could Salivary microRNAs Be an Opportunity for Ovarian Cancer Diagnostics?"],"prefix":"10.3390","volume":"11","author":[{"given":"Marzia","family":"Robotti","sequence":"first","affiliation":[{"name":"Graduate School in Translational Medicine, Scuola Superiore Sant\u2019Anna, Via G. Moruzzi, 56124 Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Scebba","sequence":"additional","affiliation":[{"name":"Health Science Interdisciplinary Center, Scuola Superiore Sant\u2019Anna, Via G. Moruzzi, 56124 Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debora","family":"Angeloni","sequence":"additional","affiliation":[{"name":"Health Science Interdisciplinary Center, Scuola Superiore Sant\u2019Anna, Via G. Moruzzi, 56124 Pisa, Italy"},{"name":"The Institute of Biorobotics, Scuola Superiore Sant\u2019Anna, Via G. Moruzzi, 56124 Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,2,21]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"9","DOI":"10.20892\/j.issn.2095-3941.2016.0084","article-title":"Epidemiology of Ovarian Cancer: A Review","volume":"14","author":"Reid","year":"2017","journal-title":"Cancer Biol. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21442","article-title":"Cancer Statistics, 2018","volume":"68","author":"Siegel","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/S0140-6736(15)01224-6","article-title":"Ovarian Cancer Screening and Mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): A Randomised Controlled Trial","volume":"387","author":"Jacobs","year":"2016","journal-title":"Lancet"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1159\/000479006","article-title":"Ovarian Cancer: A Heterogeneous Disease","volume":"85","author":"Leary","year":"2018","journal-title":"Pathobiology"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"S118","DOI":"10.1016\/S0020-7292(12)60025-3","article-title":"Cancer of the Ovary, Fallopian Tube, and Peritoneum","volume":"119","author":"Berek","year":"2012","journal-title":"Int. J. Gynecol. Obstet."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1001\/jama.2011.766","article-title":"Effect of Screening on Ovarian Cancer Mortality: The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial","volume":"305","author":"Buys","year":"2011","journal-title":"JAMA J. Am. Med. Assoc."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1158\/1055-9965.EPI-10-0580","article-title":"The Road from Discovery to Clinical Diagnostics: Lessons Learned from the First FDA-Cleared In Vitro Diagnostic Multivariate Index Assay of Proteomic Biomarkers","volume":"19","author":"Zhang","year":"2010","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.ygyno.2015.09.010","article-title":"Assessing the Risk of Ovarian Malignancy Algorithm for the Conservative Management of Women with a Pelvic Mass","volume":"139","author":"Lokich","year":"2015","journal-title":"Gynecol. Oncol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1084\/jem.121.3.439","article-title":"Demonstration of Tumor-Specific Antigens in Human Colonic Carcinomata By Immunological Tolerance and Absorption Techniques","volume":"121","author":"Gold","year":"1965","journal-title":"J. Exp. Med."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Lee, J.M., and Kohn, E.C. (2010, January 8\u201312). Proteomics as a Guiding Tool for More Effective Personalized Therapy. Proceedings of the Annals of Oncology, Milan, Italy.","DOI":"10.1093\/annonc\/mdq375"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"7677","DOI":"10.1073\/pnas.0502178102","article-title":"Serum Protein Markers for Early Detection of Ovarian Cancer","volume":"102","author":"Mor","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1038\/sj.bjc.6606092","article-title":"HE4 and CA125 as a Diagnostic Test in Ovarian Cancer: Prospective Validation of the Risk of Ovarian Malignancy Algorithm","volume":"104","author":"Cadron","year":"2011","journal-title":"Br. J. Cancer"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Li, F., Tie, R., Chang, K., Wang, F., Deng, S., Lu, W., Yu, L., and Chen, M. (2012). Does Risk for Ovarian Malignancy Algorithm Excel Human Epididymis Protein 4 and CA125 in Predicting Epithelial Ovarian Cancer: A Meta-Analysis. BMC Cancer, 12.","DOI":"10.1186\/1471-2407-12-258"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1373\/clinchem.2009.140855","article-title":"A Recipe for Proteomics Diagnostic Test Development: The OVA1 Test, from Biomarker Discovery to FDA Clearance","volume":"56","author":"Fung","year":"2010","journal-title":"Clin. Chem."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"188503","DOI":"10.1016\/j.bbcan.2021.188503","article-title":"Roles of CA125 in Diagnosis, Prediction, and Oncogenesis of Ovarian Cancer","volume":"1875","author":"Zhang","year":"2021","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"20170571","DOI":"10.1259\/bjr.20170571","article-title":"Ovarian Cancer Screening-Ultrasound; Impact on Ovarian Cancer Mortality","volume":"91","author":"Kamal","year":"2018","journal-title":"Br. J. Radiol."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Elorriaga, M.\u00c1., Neyro, J.L., Mieza, J., Crist\u00f3bal, I., and Llueca, A. (2021). Biomarkers in Ovarian Pathology: From Screening to Diagnosis. Review of the Literature. J. Pers. Med., 11.","DOI":"10.3390\/jpm11111115"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.ygyno.2019.04.006","article-title":"Multiple Biomarker Algorithms to Predict Epithelial Ovarian Cancer in Women with a Pelvic Mass: Can Additional Makers Improve Performance?","volume":"154","author":"Moore","year":"2019","journal-title":"Gynecol. Oncol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/s41416-019-0544-0","article-title":"Diagnosis of Epithelial Ovarian Cancer Using a Combined Protein Biomarker Panel","volume":"121","author":"Russell","year":"2019","journal-title":"Br. J. Cancer"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1016\/j.jprot.2010.05.013","article-title":"Proteomics and Ovarian Cancer: Integrating Proteomics Information into Clinical Care","volume":"73","author":"Hays","year":"2010","journal-title":"J. Proteom."},{"key":"ref_22","first-page":"329","article-title":"Utility of Mesothelin, L1CAM and Afamin as Biomarkers in Primary Ovarian Cancer","volume":"33","author":"Aktas","year":"2013","journal-title":"Anticancer Res."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Setti, G., Pezzi, M.E., Viani, M.V., Pertinhez, T.A., Cassi, D., Magnoni, C., Bellini, P., Musolino, A., Vescovi, P., and Meleti, M. (2020). Salivary MicroRNA for Diagnosis of Cancer and Systemic Diseases: A Systematic Review. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21030907"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Ueland, F. (2017). A Perspective on Ovarian Cancer Biomarkers: Past, Present and Yet-To-Come. Diagnostics, 7.","DOI":"10.3390\/diagnostics7010014"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1001\/jama.2017.21926","article-title":"Screening for Ovarian Cancer US Preventive Services Task Force Recommendation Statement","volume":"319","author":"Grossman","year":"2018","journal-title":"JAMA J. Am. Med. Assoc."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/jbio.201600154","article-title":"Direct and Label-Free Detection of the Human Growth Hormone in Urine by an Ultrasensitive Bimodal Waveguide Biosensor","volume":"10","author":"Maldonado","year":"2017","journal-title":"J. Biophotonics"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"e16","DOI":"10.1017\/S0266462322000010","article-title":"Understanding Innovation of Health Technology Assessment Methods: The IHTAM Framework","volume":"38","author":"Jiu","year":"2022","journal-title":"Int. J. Technol. Assess. Health Care"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/s41467-021-26615-y","article-title":"The DNA Methylome of Cervical Cells Can Predict the Presence of Ovarian Cancer","volume":"13","author":"Barrett","year":"2022","journal-title":"Nat. Commun."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"104001","DOI":"10.1016\/j.ebiom.2022.104001","article-title":"Multi-Omics Approaches for Biomarker Discovery in Early Ovarian Cancer Diagnosis-NC-ND License","volume":"79","author":"Xiao","year":"2022","journal-title":"EBioMedicine"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1038\/s41416-022-01925-0","article-title":"A Novel Circulating MiRNA Panel for Non-Invasive Ovarian Cancer Diagnosis and Prognosis","volume":"127","author":"Gahlawat","year":"2022","journal-title":"Br. J. Cancer"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1001\/jamaoncol.2018.0028","article-title":"The yet Unrealized Promise of Ovarian Cancer Screening","volume":"4","author":"Drescher","year":"2018","journal-title":"JAMA Oncol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1056\/NEJMe1914488","article-title":"Personalized Medicine for Primary Treatment of Serous Ovarian Cancer","volume":"381","author":"Longo","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s12033-007-9013-8","article-title":"The MicroRNA (MiRNA): Overview of the RNA Genes That Modulate Gene Function","volume":"38","author":"Ying","year":"2008","journal-title":"Mol. Biotechnol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/35040556","article-title":"Degnan Bernard Conservation of the Sequence and Temporal Expression of Let-7 Heterochronic Regulatory RNA","volume":"408","author":"Pasquinelli","year":"2000","journal-title":"Nature"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"15524","DOI":"10.1073\/pnas.242606799","article-title":"Frequent Deletions and Down-Regulation of Micro-RNA Genes MiR15 and MiR16 at 13q14 in Chronic Lymphocytic Leukemia","volume":"99","author":"Calin","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"9330","DOI":"10.1074\/jbc.M413394200","article-title":"Dicer Is Required for Embryonic Angiogenesis during Mouse Development","volume":"280","author":"Yang","year":"2005","journal-title":"J. Biol. Chem."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/j.1365-2141.2008.07077.x","article-title":"Detection of Elevated Levels of Tumour-Associated MicroRNAs in Serum of Patients with Diffuse Large B-Cell Lymphoma","volume":"141","author":"Lawrie","year":"2008","journal-title":"Br. J. Haematol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"10513","DOI":"10.1073\/pnas.0804549105","article-title":"Circulating MicroRNAs as Stable Blood-Based Markers for Cancer Detection","volume":"105","author":"Mitchell","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1038\/cr.2008.282","article-title":"Characterization of MicroRNAs in Serum: A Novel Class of Biomarkers for Diagnosis of Cancer and Other Diseases","volume":"18","author":"Chen","year":"2008","journal-title":"Cell Res."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Larrea, E., Sole, C., Manterola, L., Goicoechea, I., Armesto, M., Arestin, M., Caffarel, M.M., Araujo, A.M., Araiz, M., and Fernandez-Mercado, M. (2016). New Concepts in Cancer Biomarkers: Circulating MiRNAs in Liquid Biopsies. Int. J. Mol. Sci., 17.","DOI":"10.3390\/ijms17050627"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s10147-017-1104-3","article-title":"Circulating MicroRNAs and Extracellular Vesicles as Potential Cancer Biomarkers: A Systematic Review","volume":"22","author":"Matsuzaki","year":"2017","journal-title":"Int. J. Clin. Oncol."},{"key":"ref_42","first-page":"1461","article-title":"Extracellular MicroRNA in Liquid Biopsy: Applicability in Cancer Diagnosis and Prevention","volume":"7","author":"Izzotti","year":"2016","journal-title":"Am. J. Cancer Res."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ygyno.2008.04.033","article-title":"MicroRNA Signatures of Tumor-Derived Exosomes as Diagnostic Biomarkers of Ovarian Cancer","volume":"110","author":"Taylor","year":"2008","journal-title":"Gynecol. Oncol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/sj.bjc.6605901","article-title":"MicroRNA in Lung Cancer","volume":"103","author":"Lin","year":"2010","journal-title":"Br. J. Cancer"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"572","DOI":"10.2174\/156800909788486731","article-title":"Potential Uses of MicroRNA in Lung Cancer Diagnosis, Prognosis, and Therapy","volume":"9","author":"Wang","year":"2009","journal-title":"Curr. Cancer Drug Targets"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/1476-4598-8-102","article-title":"MicroRNAs in Colorectal Cancer: Translation of Molecular Biology into Clinical Application","volume":"8","author":"Slaby","year":"2009","journal-title":"Mol. Cancer"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1631\/jzus.B1400184","article-title":"ping MicroRNAs in Breast Cancer: Oncogene and Tumor Suppressors with Clinical Potential","volume":"16","author":"Wang","year":"2015","journal-title":"J. Zhejiang Univ. Sci. B"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"12007","DOI":"10.3748\/wjg.v20.i34.12007","article-title":"MicroRNAs as Potential Biomarkers for Gastric Cancer. No. 2012AA020103","volume":"20","author":"Liu","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"249393","DOI":"10.1155\/2014\/249393","article-title":"The Role of MicroRNAs in Ovarian Cancer","volume":"2014","author":"Kinose","year":"2014","journal-title":"Biomed Res. Int."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1158\/1078-0432.CCR-07-1731","article-title":"MicroRNA Expression Profiles in Serous Ovarian Carcinoma","volume":"14","author":"Nam","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"F77","DOI":"10.1677\/ERC-09-0203","article-title":"MicroRNAs in Ovarian Carcinomas","volume":"17","author":"Dahiya","year":"2010","journal-title":"Endocr. Relat. Cancer"},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"K\u00f6 Bel, M., Kalloger, S.E., Boyd, N., Mckinney, S., Mehl, E., Palmer, C., Leung, S., Bowen, N.J., Ionescu, D.N., and Rajput, A. (2008). Ovarian Carcinoma Subtypes Are Different Diseases: Implications for Biomarker Studies. PLoS Med., 5.","DOI":"10.1371\/journal.pmed.0050232"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1007\/s12094-015-1303-1","article-title":"Expression of Serum MiR-200a, MiR-200b, and MiR-200c as Candidate Biomarkers in Epithelial Ovarian Cancer and Their Association with Clinicopathological Features","volume":"17","author":"Zuberi","year":"2015","journal-title":"Clin. Transl. Oncol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"5882","DOI":"10.1158\/0008-5472.CAN-04-0746","article-title":"Three Biomarkers Identified from Serum Proteomic Analysis for the Detection of Early Stage Ovarian Cancer","volume":"64","author":"Zhang","year":"2004","journal-title":"Cancer Res."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/s41571-018-0035-x","article-title":"Clinical Utility of Circulating Non-Coding RNAs\u2014An Update","volume":"15","author":"Anfossi","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Ravegnini, G., de Iaco, P., Gorini, F., Dondi, G., Klooster, I., de Crescenzo, E., Bovicelli, A., Hrelia, P., Perrone, A.M., and Angelini, S. (2021). Role of Circulating Mirnas in Therapeutic Response in Epithelial Ovarian Cancer: A Systematic Revision. Biomedicines, 9.","DOI":"10.3390\/biomedicines9101316"},{"key":"ref_57","first-page":"123","article-title":"Advances in Circulating MicroRNAs as Diagnostic and Prognostic Markers for Ovarian Cancer","volume":"10","author":"Zheng","year":"2013","journal-title":"Cancer Biol. Med."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"276","DOI":"10.21037\/atm.2017.05.13","article-title":"Circulating Biomarkers in Epithelial Ovarian Cancer Diagnosis: From Present to Future Perspective","volume":"5","author":"Montagnana","year":"2017","journal-title":"Ann. Transl. Med."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1373\/clinchem.2010.147405","article-title":"The MicroRNA Spectrum in 12 Body Fluids","volume":"56","author":"Weber","year":"2010","journal-title":"Clin. Chem."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1016\/j.celrep.2018.10.014","article-title":"Large Differences in Small RNA Composition Between Human Biofluids","volume":"25","author":"Godoy","year":"2018","journal-title":"Cell Rep."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.3389\/fphar.2019.01500","article-title":"Non-Exosomal and Exosomal Circulatory MicroRNAs: Which Are More Valid as Biomarkers?","volume":"10","author":"Shahidan","year":"2020","journal-title":"Front. Pharmacol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s12943-022-01525-9","article-title":"Liquid Biopsy: Exosomal MicroRNAs as Novel Diagnostic and Prognostic Biomarkers in Cancer","volume":"21","author":"Preethi","year":"2022","journal-title":"Mol. Cancer"},{"key":"ref_63","first-page":"175","article-title":"Extracellular\/Circulating MicroRNAs: Release Mechanisms, Functions and Challenges","volume":"10","author":"Sohel","year":"2016","journal-title":"Achiev. Life Sci."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ejpb.2019.06.016","article-title":"Saliva: An all-rounder of our body","volume":"142","author":"Roblegg","year":"2019","journal-title":"Eur J Pharm Biopharm."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.advms.2017.11.002","article-title":"Human Saliva as a Diagnostic Material","volume":"63","author":"Chojnowska","year":"2018","journal-title":"Adv. Med. Sci."},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Rapado-Gonz\u00e1lez, \u00d3., Majem, B., Muinelo-Romay, L., L\u00f3pez-L\u00f3pez, R., and Suarez-Cunqueiro, M.M. (2016). Cancer Salivary Biomarkers for Tumours Distant to the Oral Cavity. Int. J. Mol. Sci., 17.","DOI":"10.3390\/ijms17091531"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1373\/clinchem.2011.176941","article-title":"The Human Salivary RNA Transcriptome Revealed by Massively Parallel Sequencing","volume":"58","author":"Spielmann","year":"2012","journal-title":"Clin. Chem."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1373\/clinchem.2014.230433","article-title":"The Landscape of MicroRNA, Piwi-Interacting RNA, and Circular RNA in Human Saliva","volume":"61","author":"Bahn","year":"2015","journal-title":"Clin. Chem."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1373\/clinchem.2010.153767","article-title":"Diagnostic Potential of Saliva: Current State and Future Applications","volume":"57","author":"Pfaffe","year":"2011","journal-title":"Clin. Chem."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1080\/07853890.2020.1730431","article-title":"Salivary Biomarkers for Cancer Diagnosis: A Meta-Analysis","volume":"52","author":"Takkouche","year":"2020","journal-title":"Ann. Med."},{"key":"ref_71","unstructured":"Streckfus, C.F., and Guajardo-Edwards, C. The Use of Salivary as a Biometric Tool to Determine the Presence of Carcinoma of the Breast Among Women. Biometrics, 2011."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/bs.enz.2017.08.002","article-title":"Saliva-Exosomics in Cancer: Molecular Characterization of Cancer-Derived Exosomes in Saliva","volume":"Volume 42","author":"Nonaka","year":"2017","journal-title":"Enzymes"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3389\/fgene.2015.00175","article-title":"Noncoding RNAs in Human Saliva as Potential Disease Biomarkers","volume":"6","author":"Lin","year":"2015","journal-title":"Front. Genet."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"638","DOI":"10.7150\/jca.21180","article-title":"Human Salivary MicroRNAs in Cancer","volume":"9","author":"Majem","year":"2018","journal-title":"J. Cancer"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"8723","DOI":"10.1038\/s41598-020-65695-6","article-title":"MIR1246 in Body Fluids as a Biomarker for Pancreatic Cancer","volume":"10","author":"Ishige","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1097\/MPA.0000000000000383","article-title":"MiRNA-21 and MiRNA-34a Are Potential Minimally Invasive Biomarkers for the Diagnosis of Pancreatic Ductal Adenocarcinoma","volume":"45","author":"Alemar","year":"2016","journal-title":"Pancreas"},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Humeau, M., Vignolle-Vidoni, A., Sicard, F., Martins, F., Bournet, B., Buscail, L., Torrisani, J., and Cordelier, P. (2015). Salivary MicroRNA in Pancreatic Cancer Patients. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0130996"},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Rapado-Gonz\u00e1lez, \u00d3., Majem, B., \u00c1lvarez-Castro, A., D\u00edaz-Pe\u00f1a, R., Abalo, A., Su\u00e1rez-Cabrera, L., Gil-Moreno, A., Santamar\u00eda, A., L\u00f3pez-L\u00f3pez, R., and Muinelo-Romay, L. (2019). A Novel Saliva-Based Mirna Signature for Colorectal Cancer Diagnosis. J. Clin. Med., 8.","DOI":"10.3390\/jcm8122029"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.18632\/oncotarget.28036","article-title":"Exosomal and Non-Exosomal MiRNA Expression Levels in Patients with HCV-Related Cirrhosis and Liver Cancer","volume":"12","author":"Petkevich","year":"2021","journal-title":"Oncotarget"},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Ding, Y., Ma, Q., Liu, F., Zhao, L., and Wei, W. (2016). The Potential Use of Salivary Mirnas as Promising Biomarkers for Detection of Cancer: A Meta-Analysis. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0166303"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"569","DOI":"10.2174\/1389202921666191217095017","article-title":"Cell-Free MicroRNAs as Non-Invasive Diagnostic and Prognostic Biomarkers in Pancreatic Cancer","volume":"20","author":"Gablo","year":"2019","journal-title":"Curr. Genom."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1158\/1940-6207.CAPR-14-0192","article-title":"Salivary MicroRNAs Show Potential as a Noninvasive Biomarker for Detecting Resectable Pancreatic Cancer","volume":"8","author":"Xie","year":"2015","journal-title":"Cancer Prev. Res."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1002\/ijc.29324","article-title":"Combined Evaluation of a Panel of Protein and MiRNA Serum-Exosome Biomarkers for Pancreatic Cancer Diagnosis Increases Sensitivity and Specificity","volume":"136","author":"Madhavan","year":"2015","journal-title":"Int. J. Cancer"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s13353-016-0379-9","article-title":"Plasma and Saliva MiR-21 Expression in Colorectal Cancer Patients","volume":"58","author":"Sazanov","year":"2017","journal-title":"J. Appl. Genet."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"e12715","DOI":"10.7717\/peerj.12715","article-title":"Salivary MiRNAs as Non-Invasive Biomarkers of Hepatocellular Carcinoma: A Pilot Study","volume":"9","author":"Mariam","year":"2022","journal-title":"PeerJ"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.21037\/tlcr-19-530","article-title":"Salivary MicroRNAs Show Potential as Biomarkers for Early Diagnosis of Malignant Pleural Effusion","volume":"9","author":"Yang","year":"2020","journal-title":"Transl. Lung Cancer Res."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.1002\/cam4.4640","article-title":"Salivary Biomarkers in Breast Cancer Diagnosis: A Systematic Review and Diagnostic Meta-Analysis","volume":"11","author":"Koopaie","year":"2022","journal-title":"Cancer Med."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1373\/clinchem.2018.290569","article-title":"Discovery and Validation of Salivary Extracellular RNA Biomarkers for Noninvasive Detection of Gastric Cancer","volume":"64","author":"Li","year":"2018","journal-title":"Clin. Chem."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/ueg2.12328","article-title":"Gastric Cancer Detection by Non-Blood-Based Liquid Biopsies: A Systematic Review Looking into the Last Decade of Research","volume":"11","author":"Lopes","year":"2022","journal-title":"United Eur. Gastroenterol. J."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"14772","DOI":"10.1021\/am504190a","article-title":"Simultaneous Detection of Circulating OncomiRs from Body Fluids for Prostate Cancer Staging Using Nanographene Oxide","volume":"6","author":"Hizir","year":"2014","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Luedemann, C., Reinersmann, J.L., Klinger, C., Degener, S., Dreger, N.M., Roth, S., Kaufmann, M., and Savelsbergh, A. (2022). Prostate Cancer-Associated MiRNAs in Saliva: First Steps to an Easily Accessible and Reliable Screening Tool. Biomolecules, 12.","DOI":"10.3390\/biom12101366"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.3892\/or.2016.5021","article-title":"MIR 1246 and MIR-4644 in Salivary Exosome as Potential Biomarkers for Pancreatobiliary Tract Cancer","volume":"36","author":"Machida","year":"2016","journal-title":"Oncol. Rep."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s00109-011-0829-0","article-title":"Salivary Transcriptomic Biomarkers for Detection of Ovarian Cancer: For Serous Papillary Adenocarcinoma","volume":"90","author":"Lee","year":"2012","journal-title":"J. Mol. Med."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1080\/00365513.2020.1852478","article-title":"Clinical Significance of Combining Salivary MRNAs and Carcinoembryonic Antigen for Ovarian Cancer Detection","volume":"81","author":"Yang","year":"2021","journal-title":"Scand. J. Clin. Lab. Investig."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1111\/jog.13576","article-title":"Significance of Blood and Salivary IEX-1 Expression in Diagnosis of Epithelial Ovarian Carcinoma","volume":"44","author":"Li","year":"2018","journal-title":"J. Obstet. Gynaecol. Res."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.ijbiomac.2017.12.014","article-title":"Identification and Validation of Salivary Proteomic Signatures for Non-Invasive Detection of Ovarian Cancer","volume":"108","author":"Tajmul","year":"2018","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13048-018-0433-9","article-title":"Determination of Sialic Acid in Saliva by Means of Surface-Enhanced Raman Spectroscopy as a Marker in Adnexal Mass Patients: Ovarian Cancer vs Benign Cases","volume":"11","year":"2018","journal-title":"J. Ovarian Res."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"102944","DOI":"10.1016\/j.vibspec.2019.102944","article-title":"Analysis of the Lipid Profile of Saliva in Ovarian and Endometrial Cancer by IR Fourier Spectroscopy","volume":"104","author":"Sarf","year":"2019","journal-title":"Vib. Spectrosc."},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"Condrat, C.E., Thompson, D.C., Barbu, M.G., Bugnar, O.L., Boboc, A., Cretoiu, D., Suciu, N., Cretoiu, S.M., and Voinea, S.C. (2020). MiRNAs as Biomarkers in Disease: Latest Findings Regarding Their Role in Diagnosis and Prognosis. Cells, 9.","DOI":"10.3390\/cells9020276"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s12943-016-0536-0","article-title":"Clinical Relevance of Circulating Cell-Free MicroRNAs in Ovarian Cancer","volume":"15","author":"Nakamura","year":"2016","journal-title":"Mol. Cancer"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"3435","DOI":"10.1111\/cas.14599","article-title":"The Clinical Impact of Intra- and Extracellular MiRNAs in Ovarian Cancer","volume":"111","author":"Yoshida","year":"2020","journal-title":"Cancer Sci."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.ygyno.2020.11.018","article-title":"Candidate RNA Biomarkers in Biofluids for Early Diagnosis of Ovarian Cancer: A Systematic Review","volume":"160","author":"Hulstaert","year":"2021","journal-title":"Gynecol. Oncol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1016\/j.biopha.2018.07.073","article-title":"Ovarian Extracellular MicroRNAs as the Potential Non-Invasive Biomarkers: An Update","volume":"106","author":"Montazerian","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ygyno.2008.08.036","article-title":"The Detection of Differentially Expressed MicroRNAs from the Serum of Ovarian Cancer Patients Using a Novel Real-Time PCR Platform","volume":"112","author":"Resnick","year":"2009","journal-title":"Gynecol. Oncol."},{"key":"ref_105","doi-asserted-by":"crossref","unstructured":"Shiao, M.S., Chang, J.M., Lertkhachonsuk, A.A., Rermluk, N., and Jinawath, N. (2021). Circulating Exosomal MiRNAs as Biomarkers in Epithelial Ovarian Cancer. Biomedicines, 9.","DOI":"10.3390\/biomedicines9101433"},{"key":"ref_106","doi-asserted-by":"crossref","unstructured":"Shah, J.S., Soon, P.S., and Marsh, D.J. (2016). Comparison of Methodologies to Detect Low Levels of Hemolysis in Serum for Accurate Assessment of Serum MicroRNAs. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0153200"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.7150\/jca.30231","article-title":"Serum Exosomal MiRNA-145 and MiRNA-200c as Promising Biomarkers for Preoperative Diagnosis of Ovarian Carcinomas","volume":"10","author":"Kim","year":"2019","journal-title":"J. Cancer"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"e28932","DOI":"10.7554\/eLife.28932","article-title":"Diagnostic Potential for a Serum MiRNA Neural Network for Detection of Ovarian Cancer","volume":"6","author":"Elias","year":"2017","journal-title":"EIlife"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"681872","DOI":"10.3389\/fonc.2021.681872","article-title":"Evaluation of Diagnostic Potential of Epigenetically Deregulated MiRNAs in Epithelial Ovarian Cancer","volume":"11","author":"Kumar","year":"2021","journal-title":"Front. Oncol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1042\/BST20180286","article-title":"Detecting Ovarian Cancer Using Extracellular Vesicles: Progress and Possibilities","volume":"47","author":"Carollo","year":"2019","journal-title":"Biochem. Soc. Trans."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"188395","DOI":"10.1016\/j.bbcan.2020.188395","article-title":"Extracellular Vesicle-Based Liquid Biopsy Holds Great Promise for the Management of Ovarian Cancer","volume":"1874","author":"Zheng","year":"2020","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"1010428317695525","DOI":"10.1177\/1010428317695525","article-title":"Beyond Circulating MicroRNA Biomarkers: Urinary MicroRNAs in Ovarian and Breast Cancer","volume":"39","author":"Gasparri","year":"2017","journal-title":"Tumor Biol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"121","DOI":"10.4149\/neo_2016_015","article-title":"Supernatant versus Exosomal Urinary MicroRNAs. Two Fractions with Different Outcomes in Gynaecological Cancers","volume":"63","author":"Zavesky","year":"2016","journal-title":"Neoplasma"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1007\/s12253-015-9914-y","article-title":"Evaluation of Cell-Free Urine MicroRNAs Expression for the Use in Diagnosis of Ovarian and Endometrial Cancers. A Pilot Study","volume":"21","author":"Turyna","year":"2015","journal-title":"Pathol. Oncol. Res."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.3892\/or.2015.3937","article-title":"Urinary MicroRNA-30a-5p Is a Potential Biomarker for Ovarian Serous Adenocarcinoma","volume":"33","author":"Zhou","year":"2015","journal-title":"Oncol. Rep."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00404-021-06287-1","article-title":"Evaluation of Circulating MicroRNAs as Non-Invasive Biomarkers in the Diagnosis of Ovarian Cancer: A Case\u2013Control Study","volume":"306","author":"Berner","year":"2022","journal-title":"Arch. Gynecol. Obstet."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1080\/07357907.2019.1663208","article-title":"Ovarian Cancer: Differentially Expressed MicroRNAs in Tumor Tissue and Cell-Free Ascitic Fluid as Potential Novel Biomarkers","volume":"37","author":"Weinberger","year":"2019","journal-title":"Cancer Investig."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1002\/cncy.22143","article-title":"MicroRNA Profiling in Serous Cavity Specimens: Diagnostic Challenges and New Opportunities","volume":"127","author":"Cappello","year":"2019","journal-title":"Cancer Cytopathol."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1177\/1933719118776808","article-title":"Ascites-Derived Extracellular MicroRNAs as Potential Biomarkers for Ovarian Cancer","volume":"26","author":"Weinberger","year":"2019","journal-title":"Reprod. Sci."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s13048-018-0391-2","article-title":"Comparison of Benign Peritoneal Fluid- and Ovarian Cancer Ascites-Derived Extracellular Vesicle RNA Biomarkers","volume":"11","author":"Yamamoto","year":"2018","journal-title":"J. Ovarian Res."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1093\/carcin\/bgu130","article-title":"Exosome-Derived MiRNAs and Ovarian Carcinoma Progression","volume":"35","author":"Vaksman","year":"2014","journal-title":"Carcinogenesis"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"9149","DOI":"10.1038\/s41598-021-88163-1","article-title":"Extracellular Vesicles Derived from Ascitic Fluid Enhance Growth and Migration of Ovarian Cancer Cells","volume":"11","author":"Mitra","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"215735","DOI":"10.1016\/j.canlet.2022.215735","article-title":"Integrated Analysis of Ascites and Plasma Extracellular Vesicles Identifies a MiRNA-Based Diagnostic Signature in Ovarian Cancer","volume":"542","author":"Wang","year":"2022","journal-title":"Cancer Lett."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.neo.2021.12.008","article-title":"RNA Biomarkers from Proximal Liquid Biopsy for Diagnosis of Ovarian Cancer","volume":"24","author":"Hulstaert","year":"2022","journal-title":"Neoplasia"},{"key":"ref_125","doi-asserted-by":"crossref","unstructured":"Skryabin, G.O., Komelkov, A.V., Zhordania, K.I., Bagrov, D.V., Vinokurova, S.V., Galetsky, S.A., Elkina, N.V., Denisova, D.A., Enikeev, A.D., and Tchevkina, E.M. (2022). Extracellular Vesicles from Uterine Aspirates Represent a Promising Source for Screening Markers of Gynecologic Cancers. Cells, 11.","DOI":"10.3390\/cells11071064"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.bbcan.2019.05.007","article-title":"Clinical Validity of Saliva and Novel Technology for Cancer Detection","volume":"1872","author":"Wei","year":"2019","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"100825","DOI":"10.1016\/j.mam.2019.10.002","article-title":"Circulating MiRNA Analysis for Cancer Diagnostics and Therapy","volume":"72","author":"Valihrach","year":"2020","journal-title":"Mol. Asp. Med."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1089\/dna.2016.3426","article-title":"Circulating MicroRNAs: Promising Biomarkers Involved in Several Cancers and Other Diseases","volume":"36","author":"Zhao","year":"2017","journal-title":"DNA Cell Biol."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s11912-019-0816-0","article-title":"Novel Approaches to Ovarian Cancer Screening","volume":"21","author":"Nebgen","year":"2019","journal-title":"Curr. Oncol. Rep."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13048-019-0503-7","article-title":"Biomarkers and Algorithms for Diagnosis of Ovarian Cancer: CA125, HE4, RMI and ROMA, a Review","volume":"12","author":"Dochez","year":"2019","journal-title":"J. Ovarian Res."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1364\/OPN.31.4.000024","article-title":"Nanophotonic Biosensors Driving Personalized Medicine","volume":"31","author":"Soler","year":"2020","journal-title":"Opt. Photonics News"},{"key":"ref_132","unstructured":"Marin, Y., Velha, P., Faralli, S., Di Pasquale, F., and Oton, C.J. (2018). Optical Sensors, Optica Publishing Group. Optical Sensors and Sensing Congress (ES, FTS, HISE, Sensors)."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1109\/JSTQE.2009.2032510","article-title":"Label-Free Biosensor Arrays Based on Silicon Ring Resonators and High-Speed Optical Scanning Instrumentation","volume":"16","author":"Iqbal","year":"2010","journal-title":"IEEE J. Sel. Top. Quantum Electron."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.bios.2012.03.037","article-title":"Label-Free, Multiplexed Detection of Bacterial TmRNA Using Silicon Photonic Microring Resonators","volume":"36","author":"Scheler","year":"2012","journal-title":"Biosens. Bioelectron."}],"container-title":["Biomedicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9059\/11\/3\/652\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:38:09Z","timestamp":1760121489000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9059\/11\/3\/652"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,21]]},"references-count":134,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,3]]}},"alternative-id":["biomedicines11030652"],"URL":"https:\/\/doi.org\/10.3390\/biomedicines11030652","relation":{},"ISSN":["2227-9059"],"issn-type":[{"value":"2227-9059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,21]]}}}